Primary care practitioners serve a critical role in optimizing clinical outcomes for adults with type 2 diabetes.

Research found that the weight-loss medications may reduce the spread of several obesity-related cancers, including lung, ...

An interview discussing recent research on the association between GLP-1 receptor agonist use and the risk of atrial fibrillation.

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...

The World Health Organization issued new guidelines Monday recommending the use of GLP-1 drugs for treating obesity. In the new guidelines, the United Nations health agency made two key ...

Share on Pinterest Could drugs like Ozempic lower major complications risk after a heart attack? A study in mice shows promise. Image credit: Steve Christo – Corbis/Corbis via Getty Images Recent ...

The World Health Organization has issued its first guidance on the use of GLP-1 therapies for chronic, relapsing obesity, making it part of the agency’s broader plan to address the global obesity ...